- Home
- BRX vs LNTH Comparison
BRX vs LNTH Comparison
Compare BRX & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRX | LNTH |
|---|---|---|
| Founded | 2011 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 4.4B |
| IPO Year | 2013 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BRX | LNTH |
|---|---|---|
| Price | $26.28 | $66.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | $29.82 | ★ $78.00 |
| AVG Volume (30 Days) | ★ 2.7M | 1.1M |
| Earning Date | 02-09-2026 | 11-06-2025 |
| Dividend Yield | ★ 4.69% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.08 | ★ 2.39 |
| Revenue | $1,346,289,000.00 | ★ $1,525,933,000.00 |
| Revenue This Year | $7.62 | $0.01 |
| Revenue Next Year | $4.41 | $0.52 |
| P/E Ratio | ★ $24.28 | $27.81 |
| Revenue Growth | ★ 5.75 | 1.95 |
| 52 Week Low | $22.29 | $47.25 |
| 52 Week High | $28.61 | $111.29 |
Technical Indicators
Market Signals| Indicator | BRX | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 53.72 | 65.16 |
| Support Level | $25.58 | $66.20 |
| Resistance Level | $26.46 | $67.45 |
| Average True Range (ATR) | 0.35 | 1.71 |
| MACD | 0.11 | -0.08 |
| Stochastic Oscillator | 78.92 | 75.54 |
Price Performance
Historical ComparisonAbout BRX Brixmor Property Group Inc.
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.